Linden Advisors’s MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share MDH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-179,250
Closed -$142K 761
2021
Q2
$142K Buy
+179,250
New +$108K ﹤0.01% 731

Other funds holding MDH.WS

Linden Advisors's MDH.WS Position: Q3 2021 in Review

Linden Advisors sold out of MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (MDH.WS) in Q3 2021, closing a stake of 179,250 shares — an estimated $142K sold.

Linden Advisors first reported a position in MDH.WS in Q2 2021 and held it in 1 quarter. The position peaked at $142K in Q2 2021. 56 funds tracked by Wall St. Rank hold MDH.WS as of Q3 2021.

  • Linden Advisors reported no remaining MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q3 2021 after selling out during the quarter.
  • Linden Advisors sold 179,250 MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q3 2021, an estimated $142K.
  • Linden Advisors first reported a position in MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 1 quarter.
  • Linden Advisors's MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $142K in Q2 2021.
  • 56 funds tracked by Wall St. Rank held MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q3 2021.

Based on Linden Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.